268 related articles for article (PubMed ID: 28589395)
41. Testosterone and prostate cancer: revisiting old paradigms.
Isbarn H; Pinthus JH; Marks LS; Montorsi F; Morales A; Morgentaler A; Schulman C
Eur Urol; 2009 Jul; 56(1):48-56. PubMed ID: 19375844
[TBL] [Abstract][Full Text] [Related]
42. Is testosterone a friend or a foe of the prostate?
Jannini EA; Gravina GL; Morgentaler A; Morales A; Incrocci L; Hellstrom WJ
J Sex Med; 2011 Apr; 8(4):946-55. PubMed ID: 21457469
[TBL] [Abstract][Full Text] [Related]
43. Testosterone replacement therapy and prostate cancer.
Morgentaler A
Urol Clin North Am; 2007 Nov; 34(4):555-63, vii. PubMed ID: 17983895
[TBL] [Abstract][Full Text] [Related]
44. Testosterone therapy in men with prostate cancer: scientific and ethical considerations.
Morgentaler A
J Urol; 2009 Mar; 181(3):972-9. PubMed ID: 19150547
[TBL] [Abstract][Full Text] [Related]
45. Testosterone treatment in the aging male: myth or reality?
Nigro N; Christ-Crain M
Swiss Med Wkly; 2012; 142():w13539. PubMed ID: 22430839
[TBL] [Abstract][Full Text] [Related]
46. Androgen replacement after curative radical prostatectomy for prostate cancer in hypogonadal men.
Kaufman JM; Graydon RJ
J Urol; 2004 Sep; 172(3):920-2. PubMed ID: 15310998
[TBL] [Abstract][Full Text] [Related]
47. Critical review: is watchful waiting a viable management option for older men with prostate cancer?
Bailey DE; Wallace M
Am J Mens Health; 2007 Mar; 1(1):18-28. PubMed ID: 19482780
[TBL] [Abstract][Full Text] [Related]
48. Testosterone supplementation does not worsen lower urinary tract symptoms.
Pearl JA; Berhanu D; François N; Masson P; Zargaroff S; Cashy J; McVary KT
J Urol; 2013 Nov; 190(5):1828-33. PubMed ID: 23764078
[TBL] [Abstract][Full Text] [Related]
49. Testosterone Deficiency: A Review and Comparison of Current Guidelines.
Kwong JCC; Krakowsky Y; Grober E
J Sex Med; 2019 Jun; 16(6):812-820. PubMed ID: 31080101
[TBL] [Abstract][Full Text] [Related]
50. Use of testosterone replacement therapy in patients with prostate cancer.
Dorff TB; Vogelzang NJ
Curr Urol Rep; 2011 Jun; 12(3):223-8. PubMed ID: 21365235
[TBL] [Abstract][Full Text] [Related]
51. The safety of testosterone supplementation therapy in prostate cancer.
Dupree JM; Langille GM; Khera M; Lipshultz LI
Nat Rev Urol; 2014 Sep; 11(9):526-30. PubMed ID: 25069737
[TBL] [Abstract][Full Text] [Related]
52. Hypogonadism and its treatment among prostate cancer survivors.
Choi EJ; Xu P; El-Khatib FM; Huynh LM; Yafi FA
Int J Impot Res; 2021 May; 33(4):480-487. PubMed ID: 33311575
[TBL] [Abstract][Full Text] [Related]
53. Does testosterone replacement therapy increase the risk of conversion to treatment in patients with prostate cancer on active surveillance?
Daza J; Ahmad A; Shabir U; Jing Z; Shiekh M; Kauffman E; Guru KA; Hussein AA
Urol Oncol; 2023 Oct; 41(10):429.e1-429.e7. PubMed ID: 37423815
[TBL] [Abstract][Full Text] [Related]
54. Registry of Hypogonadism in Men (RHYME): design of a multi-national longitudinal, observational registry of exogenous testosterone use in hypogonadal men.
Rosen RC; Wu FC; Behre HM; Roehrborn CG; Schröder FH; Siami FS; Martha JF; Finn JD; Araujo AB
Aging Male; 2013 Mar; 16(1):1-7. PubMed ID: 23373674
[TBL] [Abstract][Full Text] [Related]
55. Evidence-based approach to active surveillance of prostate cancer.
Witherspoon L; Breau RH; Lavallée LT
World J Urol; 2020 Mar; 38(3):555-562. PubMed ID: 30726506
[TBL] [Abstract][Full Text] [Related]
56. [Effect of transderrmal testosterone on the quality of life of men with androgen deficiency and chronic prostatitis in routine clinical practice].
Vinarov AZ; Rozhivanov RV
Urologiia; 2018 Mar; (1):71-76. PubMed ID: 29634137
[TBL] [Abstract][Full Text] [Related]
57. A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management.
Grossmann M; Matsumoto AM
J Clin Endocrinol Metab; 2017 Mar; 102(3):1067-1075. PubMed ID: 28359097
[TBL] [Abstract][Full Text] [Related]
58. Active surveillance for prostate cancer.
Romero-Otero J; García-Gómez B; Duarte-Ojeda JM; Rodríguez-Antolín A; Vilaseca A; Carlsson SV; Touijer KA
Int J Urol; 2016 Mar; 23(3):211-8. PubMed ID: 26621054
[TBL] [Abstract][Full Text] [Related]
59. Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy.
Sarosdy MF
Cancer; 2007 Feb; 109(3):536-41. PubMed ID: 17183557
[TBL] [Abstract][Full Text] [Related]
60. Testosterone administration in older men.
Matsumoto AM
Endocrinol Metab Clin North Am; 2013 Jun; 42(2):271-86. PubMed ID: 23702401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
